EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Nanocarriers for topical minoxidil in androgenetic alopecia: systematic review of preclinical and clinical evidence

Heloisa da Rocha Picado Copesco, Gustavo Sartori Albertino, Filipe Rocha Lima, Antonio Claudio Tedesco, Marco Andrey Cipriani Frade

Anais Brasileiros de Dermatologia · 2026

DOI: 10.1016/j.abd.2026.501400 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Anais Brasileiros de Dermatologia, 2026. Verfasst von Heloisa da Rocha Picado Copesco und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Dermatology, Faculdade de Medicina de Ribeirão Preto, Hospital das Clínicas, Universidade de São Paulo, …. Hauptthemen laut MEDLINE: Minoxidil, Alopecia, Nanoparticles, Drug Carriers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Androgenetic Alopecia (AGA) is the most prevalent hair disorder. Conventional topical minoxidil is limited by suboptimal follicular penetration, local adverse effects, and poor adherence; nanocarrier-based ‘‘nanominoxidil’’ systems may optimize delivery, but their clinical value remains uncertain.

Objective

To synthesize experimental and clinical evidence on nanocarrier-based topical minoxidil for AGA.

Methods

We systematically searched databases (2015-2024) for in vitro, ex-vivo, in vivo, and human studies evaluating nanocarriers < 1000 nm loaded with minoxidil versus conventional minoxidil, placebo, or no treatment. Primary outcomes were follicular and cutaneous penetra-tion or retention; secondary outcomes included hair length, density and/or coverage, biomarker modulation, adverse events, and formulation stability. Risk of bias was assessed with SYRCLE and OHAT.

Results

Of 410 records, 20 studies met eligibility criteria, predominantly preclinical, and one evaluated cutaneous tolerability in healthy volunteers. Across platforms (lipid, polymeric, hybrid and deformable systems, nanoemulsions), nanominoxidil consistently increased follicu-lar deposition and cutaneous retention (≈2- to > 7-fold vs conventional solutions) and improved hair growth surrogates and angiogenic or stem-cell markers. Local tolerability was generally acceptable and systemic exposure was negligible when reported. Study limitations: Evidence is preclinical, with a single non-therapeutic human study; het-erogeneity across models, comparators, doses, follow-up, and outcomes, and frequent lack of randomization, blinding, and standardized safety reporting, precluded meta-analysis and limited internal validity and generalizability.

Conclusions

Nanotechnology-based minoxidil formulations enhance follicular targeting and hair-growth surrogate outcomes in experimental models and appear locally safe, but random-ized trials in patients with AGA are required before nanominoxidil can be recommended for routine clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MinoxidilAlopeciaNanoparticlesDrug CarriersHumansAnimalsAdministration, TopicalAdministration, CutaneousHair Follicle

Stichwörter der Autor:innen

Androgenetic alopeciaDrug delivery systemsHair follicleMinoxidilNanoparticlesSkin absorption

Substanzen

MinoxidilDrug Carriers

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Dermatology, Faculdade de Medicina de Ribeirão Preto, Hospital das Clínicas, Universidade de São Paulo, Ribeirão Preto, SP, Brazil; Dermatology Division, Faculty of Medicine,…
  • Department of Internal Medicine, Division of Dermatology, Faculdade de Medicina de Ribeirão Preto, Hospital das Clínicas, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
  • Department of Internal Medicine, Division of Dermatology, Faculdade de Medicina de Ribeirão Preto, Hospital das Clínicas, Universidade de São Paulo, Ribeirão Preto, SP, Brazil; Department of Biochemistry and Immunology,…
  • Center of Nanotechnology and Tissue Engineering, Photobiology and Photomedicine Research Group, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Copesco, H. D. R. P., Albertino, G. S., Lima, F. R., Tedesco, A. C., & Frade, M. A. C. (2026). Nanocarriers for topical minoxidil in androgenetic alopecia: systematic review of preclinical and clinical evidence. Anais Brasileiros de Dermatologia. https://doi.org/10.1016/j.abd.2026.501400

Vancouver

Copesco HDRP, Albertino GS, Lima FR, Tedesco AC, Frade MAC. Nanocarriers for topical minoxidil in androgenetic alopecia: systematic review of preclinical and clinical evidence. Anais Brasileiros de Dermatologia. 2026. doi:10.1016/j.abd.2026.501400

BibTeX
@article{Copesco2026,
  author = {Copesco, Heloisa da Rocha Picado and Albertino, Gustavo Sartori and Lima, Filipe Rocha and Tedesco, Antonio Claudio and Frade, Marco Andrey Cipriani},
  title = {Nanocarriers for topical minoxidil in androgenetic alopecia: systematic review of preclinical and clinical evidence},
  journal = {Anais Brasileiros de Dermatologia},
  year = {2026},
  doi = {10.1016/j.abd.2026.501400}
}
Kostenlos starten →